Freeman Health System is a three-hospital network in Joplin, Newton County, Missouri, USA. Freeman operates two campuses in Joplin and a satellite hospital in Neosho, Missouri. The largest hospital in the system, Freeman West, is a 339-bed teaching hospital with a 41-bed ICU.

There are 460 beds in Freeman Health System.

During the past decade, Freeman Health System conducted 151 clinical trials. In the 10-year time frame, 151 clinical trials started and 91 clinical trials were completed, i.e. on average, 60.3% percent of trials that started reached the finish line to date. In the past 5 years, 42 clinical trials started and 55 clinical trials were completed. i.e. 131% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Freeman Health System" #1 sponsor was "National Cancer Institute (NCI)" with 114 trials, followed by "SWOG Cancer Research Network" with 38 trials sponsored, "Alliance for Clinical Trials in Oncology" with 31 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 22 trials sponsored and "NRG Oncology" with 22 trials sponsored. Other sponsors include 23 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Freeman Health System" #1 collaborator was "National Cancer Institute (NCI)" with 117 trials as a collaborator, "NRG Oncology" with 28 trials as a collaborator, "Canadian Cancer Trials Group" with 8 trials as a collaborator, "Cancer and Leukemia Group B" with 4 trials as a collaborator and "Genentech, Inc." with 3 trials as a collaborator. Other collaborators include 29 different institutions and companies that were collaborators in the rest 31 trials.

According to Clinical.Site data, the most researched conditions in "Freeman Health System" are "Invasive Breast Carcinoma" (11 trials), "Recurrent Squamous Cell Lung Carcinoma" (10 trials), "Recurrent Ovarian Carcinoma" (9 trials), "Stage IV Lung Cancer AJCC v8" (9 trials) and "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials). Many other conditions were trialed in "Freeman Health System" in a lesser frequency.

Most popular intervention types in "Freeman Health System" are "Drug" (194 trials), "Other" (148 trials), "Biological" (99 trials), "Procedure" (66 trials) and "Radiation" (36 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (74 trials), "Quality-of-Life Assessment" (60 trials), "Biospecimen Collection" (33 trials), "Questionnaire Administration" (33 trials) and "Paclitaxel" (32 trials). Other intervention names were less common.

The vast majority of trials in "Freeman Health System" are 196 trials for "All" genders, 40 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "Freeman Health System". undefined are not yet recruiting, 70 are recruiting, 105 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 48 completed trials in Freeman Health System, 8 suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in Freeman Health System, 4 "Phase 1" clinical trials were conducted, 111 "Phase 2" clinical trials and 127 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 7 trials that are defined as “Not Applicable".

Freeman Health System has several departments that took part in Clinical trials: "Freeman Cancer Institute at Freeman Health System" - 24 trials